Bisgaier C L, Sachdev O P, Megna L, Glickman R M
J Lipid Res. 1985 Jan;26(1):11-25.
Human apoA-IV was purified from delipidated urinary chylomicrons. Monospecific antibodies were raised in rabbits and used to develop a double antibody radioimmunoassay (RIA). Displacement of 125I-labeled apoA-IV by plasma or purified chylomicron apoA-IV resulted in parallel displacement curves, indicating that apoA-IV from both sources share common antigenic determinants. The apoA-IV level in plasma from normal healthy fasting male subjects (n = 5) was 37.4 +/- 4.0 mg/dl, while fat-feeding increased the level to 49.1 +/- 7.9 mg/dl (P less than 0.05) at 4 hr. The apoA-IV level in plasma from abetalipoproteinemic fasting subjects was 13.7 +/- 3.1 mg/dl (n = 5). Plasma from a single fasting Tangier subject showed a reduced apoA-IV level of 21.1 mg/dl. The distribution of apoA-IV in fasting and postprandial plasma was determined by 6% agarose gel chromatography. Fifteen to 25% of plasma apoA-IV eluted in the region of plasma high density lipoprotein (HDL), with the remainder eluting in subsequent column fractions. In abetalipoproteinemic plasma this HDL fraction is reduced and lacks apoA-IV, suggesting that at least some of the apoA-IV on these particles is normally derived from triglyceride-rich lipoproteins. Lipemic plasma from a fat-fed subject showed a small rise (3%) in chylomicron-associated apoA-IV. Gel-filtered HDL and subsequent apoA-IV-containing fractions were subjected to 4-30% polyacrylamide gradient gel electrophoresis (4/30 GGE), and apoA-IV was identified by immunolocalization following transfer of proteins to nitrocellulose paper. In normal plasma apoA-IV was localized throughout all HDL fractions. In addition, normal plasma contained apoA-IV localized in a small particle (diameter 7.8-8.0 nm). This particle also contained apoA-I and lipid. A markedly elevated saturated to unsaturated cholesteryl ester ratio was present in gel-filtered plasma fractions containing small HDL, suggesting an intracellular origin of these particles. In abetalipoproteinemic plasma apoA-IV was absent from all HDL fractions except for the small HDL particles, suggesting that they are not derived from the surface of triglyceride-rich particles. All plasmas contained free apoA-IV. In contrast to gel-filtered plasma, lipoprotein subfractions of fasted normal plasma prepared in the ultracentrifuge primarily contained apoA-IV in the d greater than 1.26 g/ml fraction, suggesting an artifactual redistribution of the apolipoprotein during centrifugation. Overall, these data suggest that apoA-IV secretion into plasma is increased with fat feeding, and that apoA-IV normally exists as both a free apolipoprotein and in association with HDL particles.
人载脂蛋白A-IV(apoA-IV)从脱脂尿乳糜微粒中纯化得到。用其在兔体内制备单特异性抗体,并用于开发双抗体放射免疫测定法(RIA)。血浆或纯化的乳糜微粒apoA-IV对125I标记的apoA-IV的置换产生平行的置换曲线,表明来自这两种来源的apoA-IV具有共同的抗原决定簇。正常健康空腹男性受试者(n = 5)血浆中的apoA-IV水平为37.4±4.0mg/dl,而进食脂肪后4小时该水平升高至49.1±7.9mg/dl(P<0.05)。无β脂蛋白血症空腹受试者血浆中的apoA-IV水平为13.7±3.1mg/dl(n = 5)。一名空腹丹吉尔病受试者的血浆显示apoA-IV水平降低至21.1mg/dl。通过6%琼脂糖凝胶色谱法测定空腹和餐后血浆中apoA-IV的分布。15%至25%的血浆apoA-IV在血浆高密度脂蛋白(HDL)区域洗脱,其余在随后的柱馏分中洗脱。在无β脂蛋白血症血浆中,该HDL馏分减少且缺乏apoA-IV,这表明这些颗粒上的至少一些apoA-IV通常源自富含甘油三酯的脂蛋白。进食脂肪的受试者的脂血血浆中与乳糜微粒相关的apoA-IV有小幅升高(3%)。对凝胶过滤的HDL及随后含apoA-IV的馏分进行4%-30%聚丙烯酰胺梯度凝胶电泳(4/30 GGE),将蛋白质转移至硝酸纤维素纸后通过免疫定位鉴定apoA-IV。在正常血浆中,apoA-IV定位于所有HDL馏分中。此外,正常血浆中apoA-IV定位于一种小颗粒(直径7.8 - 8.0nm)中。该颗粒还含有apoA-I和脂质。含有小HDL的凝胶过滤血浆馏分中饱和与不饱和胆固醇酯的比例显著升高,表明这些颗粒起源于细胞内。在无β脂蛋白血症血浆中,除小HDL颗粒外,所有HDL馏分均不存在apoA-IV,这表明它们并非源自富含甘油三酯颗粒的表面。所有血浆均含有游离的apoA-IV。与凝胶过滤血浆不同,超速离心制备的空腹正常血浆的脂蛋白亚组分中,apoA-IV主要存在于密度大于1.26g/ml的馏分中,这表明在离心过程中载脂蛋白发生了人为重新分布。总体而言,这些数据表明进食脂肪后血浆中apoA-IV的分泌增加,且apoA-IV通常以游离载脂蛋白和与HDL颗粒结合的形式存在。